Association of polymorphisms in the Angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community.
Author: Meng Y, Baldwin CT, Bowirrat A, Waraska K, Inzelberg R, Friedland RP, Farrer LA.
Source:
The American Journal of Human Genetics, 78(5), 871-877.
Several lines of evidence support for a role of angiotensin converting enzyme
(ACE) in Alzheimer disease (AD). Most genetic studies have focused on an Alu
insertion/deletion (I/D) polymorphism in the ACE gene (DCP1) and have yielded
conflicting results. We evaluated the association between 15 single-nucleotide
polymorphisms (SNPs) in DCP1, including the I/D variant, and AD in a sample of 92
patients with AD and 166 nondemented controls from an inbred Israeli Arab
community. Although there was no evidence for association between AD and I/D, we
observed significant association with SNPs rs4343 (P = .00001) and rs4351 (P =
.01). Haplotype analysis revealed remarkably significant evidence of association
with the SNP combination rs4343 and rs4351 (global P = 7.5 x 10(-7)). Individuals
possessing the haplotype "GA" (frequency 0.21 in cases and 0.01 in controls)
derived from these SNPs had a 45-fold increased risk of developing AD (95% CI
6.0-343.2) compared with those possessing any of the other three haplotypes.
Longer range haplotypes including I/D were even more significant (lowest global P
= 1.1 x 10(-12)), but the only consistently associated alleles were in rs4343 and
rs4351. These results suggest that a variant in close proximity to rs4343 and
rs4351 modulates susceptibility to AD in this community.
Publication Types:
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't